• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模拟A2780卵巢癌细胞对金基细胞毒性药物的代谢反应。

Modeling the metabolic response of A2780 ovarian cancer cells to gold-based cytotoxic drugs.

作者信息

Vieri Walter, Ghini Veronica, Turano Paola, Massai Lara, Messori Luigi, Fondi Marco

机构信息

Department of Biology, University of Florence, Florence, Italy.

Department of Biology, University of Naples Federico II, Via Cinthia, 26 - 80126 Naples, Italy and Department of Agriculture, Food, Environment and Forestry (DAGRI), University of Florence, Florence, Italy.

出版信息

NPJ Syst Biol Appl. 2025 Jul 28;11(1):83. doi: 10.1038/s41540-025-00535-9.

DOI:10.1038/s41540-025-00535-9
PMID:40721599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12304190/
Abstract

Gold compounds are a promising class of experimental anticancer metallodrugs. Unlike platinum-based drugs, their antiproliferative effects are thought to result mainly from modulation of cancer cell metabolism rather than direct interaction with DNA. Previous NMR studies have shown that four cytotoxic gold compounds - auranofin, aurothiomalate and two gold N-heterocyclic carbenes - induce distinct metabolic changes in A2780 ovarian cancer cells, suggesting the occurrence of different mechanisms of action. To better understand these effects, we constructed a genome-scale metabolic model (GEM) of A2780 cells to analyze the NMR-detected metabolomic changes. The model successfully predicts the diverse metabolic responses induced by each gold compound and identifies common metabolic changes. These results confirm the potential of GEMs as a powerful tool for interpreting and predicting cellular responses to gold-based drugs, providing insights into their mechanisms of action and potential therapeutic applications.

摘要

金化合物是一类很有前景的实验性抗癌金属药物。与铂类药物不同,它们的抗增殖作用被认为主要源于对癌细胞代谢的调节,而非与DNA的直接相互作用。先前的核磁共振研究表明,四种具有细胞毒性的金化合物——金诺芬、硫代苹果酸金钠和两种金氮杂环卡宾——在A2780卵巢癌细胞中诱导出不同的代谢变化,这表明存在不同的作用机制。为了更好地理解这些效应,我们构建了A2780细胞的基因组规模代谢模型(GEM),以分析核磁共振检测到的代谢组学变化。该模型成功预测了每种金化合物诱导的不同代谢反应,并识别出常见的代谢变化。这些结果证实了基因组规模代谢模型作为解释和预测细胞对金基药物反应的强大工具的潜力,为其作用机制和潜在治疗应用提供了见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570f/12304190/5eb380021c73/41540_2025_535_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570f/12304190/25ee65b8bb92/41540_2025_535_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570f/12304190/6cfb986b956f/41540_2025_535_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570f/12304190/ff526050a664/41540_2025_535_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570f/12304190/5eb380021c73/41540_2025_535_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570f/12304190/25ee65b8bb92/41540_2025_535_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570f/12304190/6cfb986b956f/41540_2025_535_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570f/12304190/ff526050a664/41540_2025_535_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570f/12304190/5eb380021c73/41540_2025_535_Fig4_HTML.jpg

相似文献

1
Modeling the metabolic response of A2780 ovarian cancer cells to gold-based cytotoxic drugs.模拟A2780卵巢癌细胞对金基细胞毒性药物的代谢反应。
NPJ Syst Biol Appl. 2025 Jul 28;11(1):83. doi: 10.1038/s41540-025-00535-9.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
3
Assessing Auranofin for Second-Line Use in Chemoresistant Ovarian Cancer: Effects on Tumour Spheroid and Primary Cell Growth.评估金诺芬在化疗耐药卵巢癌二线治疗中的应用:对肿瘤球体和原代细胞生长的影响
J Cell Mol Med. 2025 Jul;29(13):e70681. doi: 10.1111/jcmm.70681.
4
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
7
Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer.聚乙二醇化脂质体阿霉素用于复发性上皮性卵巢癌
Cochrane Database Syst Rev. 2013 Jul 9;2013(7):CD006910. doi: 10.1002/14651858.CD006910.pub2.
8
A systematic overview of chemotherapy effects in ovarian cancer.卵巢癌化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):340-60. doi: 10.1080/02841860151116420.
9
Changing the paradigm in the treatment of platinum-sensitive recurrent ovarian cancer: from platinum doublets to nonplatinum doublets and adding antiangiogenesis compounds.改变铂类敏感复发性卵巢癌的治疗模式:从铂类双联到非铂类双联,并加入抗血管生成化合物。
Int J Gynecol Cancer. 2009 Dec;19 Suppl 2:S63-7. doi: 10.1111/IGC.0b013e3181c104fa.
10
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.

本文引用的文献

1
Novel NMR-Based Approach to Reveal the 'Metabolic Fingerprint' of Cytotoxic Gold Drugs in Cancer Cells.基于核磁共振的新方法揭示癌细胞中细胞毒性金药物的“代谢指纹”
J Proteome Res. 2025 Feb 7;24(2):813-823. doi: 10.1021/acs.jproteome.4c00904. Epub 2025 Jan 6.
2
Constraint-based modelling predicts metabolic signatures of low and high-grade serous ovarian cancer.基于约束的建模预测低级别和高级别浆液性卵巢癌的代谢特征。
NPJ Syst Biol Appl. 2024 Aug 24;10(1):96. doi: 10.1038/s41540-024-00418-5.
3
Unlocking the Power of Human Ferritin: Enhanced Drug Delivery of Aurothiomalate in A2780 Ovarian Cancer Cells.
解锁人铁蛋白的潜力:三巯丁二酸增强顺铂在 A2780 卵巢癌细胞中的药物递送。
Angew Chem Int Ed Engl. 2024 Oct 1;63(40):e202410791. doi: 10.1002/anie.202410791. Epub 2024 Aug 19.
4
Strategies for the design of analogs of auranofin endowed with anticancer potential.具有抗癌潜力的金诺芬类似物的设计策略。
Expert Opin Drug Discov. 2024 Jul;19(7):855-867. doi: 10.1080/17460441.2024.2355329. Epub 2024 May 27.
5
A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies.金属配合物及其抗癌活性的研究进展:来自体内研究的最新更新。
Biomed Pharmacother. 2024 Feb;171:116211. doi: 10.1016/j.biopha.2024.116211. Epub 2024 Jan 29.
6
Clinical Significance of Carnitine in the Treatment of Cancer: From Traffic to the Regulation.卡尼汀在癌症治疗中的临床意义:从交通到调控。
Oxid Med Cell Longev. 2023 Aug 10;2023:9328344. doi: 10.1155/2023/9328344. eCollection 2023.
7
Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.基于代谢建模的计算机药物靶点预测鉴定出 6 种新型可再利用药物用于黑色素瘤。
Cell Death Dis. 2023 Jul 26;14(7):468. doi: 10.1038/s41419-023-05955-1.
8
The effects of two cytotoxic gold(i) carbene compounds on the metabolism of A2780 ovarian cancer cells: mechanistic inferences through NMR analysis.两种细胞毒性金(I)卡宾化合物对A2780卵巢癌细胞代谢的影响:通过核磁共振分析得出的机制推断
RSC Adv. 2023 Jul 19;13(31):21629-21632. doi: 10.1039/d3ra04032a. eCollection 2023 Jul 12.
9
Gold Complexes in Anticancer Therapy: From New Design Principles to Particle-Based Delivery Systems.抗癌治疗中的金配合物:从新设计原则到基于颗粒的递送系统。
Angew Chem Int Ed Engl. 2023 May 22;62(22):e202218000. doi: 10.1002/anie.202218000. Epub 2023 Mar 15.
10
Recent advances in understanding the metabolic plasticity of ovarian cancer: A systematic review.卵巢癌代谢可塑性认识的最新进展:一项系统综述。
Heliyon. 2022 Nov 11;8(11):e11487. doi: 10.1016/j.heliyon.2022.e11487. eCollection 2022 Nov.